Remove Asset Management Remove Capital Raising Remove Private Equity
article thumbnail

How Merchant Banks Help Businesses Grow and Succeed

Razorpay

Avendus Capital: Leading merchant bank with a focus on M&A and private equity, providing services such as deal origination, execution, and post-merger integration. Goldman Sachs India: Global investment bank with a strong presence in India, offering services such as underwriting, M&A advisory, and equity research.

Banking 52
article thumbnail

Distressed Debt Hedge Funds: How to Become a Vulture Capitalist

Mergers and Inquisitions

As discussed in the distressed private equity article, there is no universal definition for a “distressed security” or a “distressed company.” Special Situations – This could include the events above but could also refer to investments in spin-offs, asset sales, recapitalizations, acquisitions, or capital raises.

Debt 103
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Event-Driven Hedge Funds: The Best Home for Bankers Turned Investors?

Mergers and Inquisitions

Special Situations – These funds focus on companies that are spinning off or divesting divisions, reorganizing, or otherwise going through more unusual changes (not just simple acquisitions or capital raises). All the large multi-manager funds , such as Millennium, also use event-driven strategies to some extent.

Funds 64
article thumbnail

What is Private Banking and How Does It Work?

Razorpay

This consolidated approach simplifies financial management and helps clients achieve their long-term objectives. Exclusive Investment Opportunities Private banking clients gain access to investment products and opportunities not available to the general public, such as: Private equity and hedge funds.

Banking 52
article thumbnail

Biotech Hedge Funds: A Match Made in Heaven

Mergers and Inquisitions

In technology, as a startup keeps raising capital, it normally does so at gradually higher valuations as its customers, users, and revenue grow. But in biotech, companies valuations often remain close to their total capital raised until much later in the process (i.e.,

Funds 64